Skip to content

The effect of Taurine on cognitive and physical function

Acute effects of low and high doses of Taurine on physical and cognitive functions in 60-69 years old men

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170326033146N7
Enrollment
15
Registered
2022-01-26
Start date
2022-02-20
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention 1: Intervention group 1: First, the desired tests will be performed. Subjects will be supplemented one hour before the tests. One gram of taurine supplement will be dissolved in powder in

Sponsors

Razi University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
60 Years to 69 Years

Inclusion criteria

Inclusion criteria: Gender Living in SanandajAge range 60 to 69 years BMI 18 to 24 (kg / m2) Provide valid evidence of complete vaccination of COVID19 and at least three weeks after the second dose Having the desired level of physical fitness to perform tests based on the Physical Activity Readiness Questionnaire (Q-PAR) and physician approval

Exclusion criteria

Exclusion criteria: Having any chronic disease Take any supplement in the two months before the start of the study Smoking

Design outcomes

Primary

MeasureTime frame
Balance. Timepoint: At the beginning of the study and after consuming one and six grams of taurine and a placebo. Method of measurement: Balance is measured using Timed up and go test - TUG.;Muscular endurance. Timepoint: At the beginning of the study and after consuming one and six grams of taurine and a placebo. Method of measurement: Muscular endurance is measured using the 30s chair stand test.;Cardiorespiratory endurance. Timepoint: At the beginning of the study and after consuming one and six grams of taurine and a placebo. Method of measurement: Cardiorespiratory endurance is measured using a 6-min walk test.;Cognitive function. Timepoint: At the beginning of the study and after consuming one and six grams of taurine and a placebo. Method of measurement: Cognitive function is measured using the MMSE test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahid Tadibi

Razi University

vtadibi@yahoo.com+98 83 3427 9265

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026